Rubius Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2018 to Q4 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Rubius Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2018 to Q4 2022.
  • Rubius Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2022 was -255 %, a 214% decline year-over-year.
  • Rubius Therapeutics, Inc. annual Return On Equity for 2022 was -255 %, a 214% decline from 2021.
  • Rubius Therapeutics, Inc. annual Return On Equity for 2021 was -81.2 %, a 8.58% increase from 2020.
  • Rubius Therapeutics, Inc. annual Return On Equity for 2020 was -88.8 %, a 76.2% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -255 -174 -214% Oct 1, 2022 Dec 31, 2022
Q3 2022 -193 -114 -146% Jul 1, 2022 Sep 30, 2022
Q2 2022 -127 -47.7 -60.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -103 -24.4 -31% Jan 1, 2022 Mar 31, 2022
Q4 2021 -81.2 +7.62 +8.58% Oct 1, 2021 Dec 31, 2021
Q3 2021 -78.2 -0.91 -1.18% Jul 1, 2021 Sep 30, 2021
Q2 2021 -79.1 -9.48 -13.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -78.7 -16.9 -27.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -88.8 -38.4 -76.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -77.3 -36 -87.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -69.6 -36.5 -111% Apr 1, 2020 Jun 30, 2020
Q1 2020 -61.8 -23 -59.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -50.4 +2.22 +4.22% Oct 1, 2019 Dec 31, 2019
Q3 2019 -41.3 Jul 1, 2019 Sep 30, 2019
Q2 2019 -33.1 Apr 1, 2019 Jun 30, 2019
Q1 2019 -38.9 Jan 1, 2019 Mar 31, 2019
Q4 2018 -52.6 Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.